New 9-Month pill combo could beat Drug-Resistant TB
NCT ID NCT07268664
First seen Jan 08, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This study tests a 9-month, all-oral drug combination (BLMZ) for people with rifampicin-resistant tuberculosis (TB). About 120 participants aged 12 and older will take the pills and be followed for 24 months to see if the infection clears and stays gone. The goal is to find a shorter, easier treatment that works well in Chinese patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center of Disease Prevention and Control in Kashi Area
Kashgar, Xinjiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hetian Prefecture Infectious Diseases Hospital
Hetian, Xinjiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Third People's Hospital in Aksou
Aksu, Xinjiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.